0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Letters to the Editor   |    
Dr. Siever Replies
LARRY J. SIEVER
Am J Psychiatry 2008;165:1357-1357. doi:10.1176/appi.ajp.2008.08040598r

To the Editor: I indeed thank Dr. Terao for the thought-provoking comments. As Dr. Terao explicitly notes, the overview did not attempt to comprehensively review treatment for aggression, nor did it address suicide. However, I agree that lithium may decrease limbic irritability, as do anticonvulsants, and increase “top-down brakes,” perhaps in part by enhancing serotonergic activity (1). There is indeed limited evidence that lithium is superior to anticonvulsants in the prevention of suicide (2), although a suicide-protective effect was not found in the data for 4,360 bipolar patients in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study (3).

1.Birkenhager TK, van den Broek WW, Fekkes D, Mulder PG, Moleman P, Bruijn JA: Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1084–1088
 
2.Sondergard L, Lopez AG, Andersen PK, Kessing LV: Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipolar Disord 2008; 10:87–94
 
3.Marangell LB, Dennehy EB, Wisniewski SR, Bauer MS, Miyahara S, Allen MH, Martinez M, Al Jurdi RK, Thase ME: Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD. J Clin Psychiatry 2008; 8:e1–e7
 
+

References

+The author’s disclosures accompany the original article.

+This letter (doi: 10.1176/appi.ajp.2008.08040598r) was accepted for publication in June 2008.

+

References

1.Birkenhager TK, van den Broek WW, Fekkes D, Mulder PG, Moleman P, Bruijn JA: Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1084–1088
 
2.Sondergard L, Lopez AG, Andersen PK, Kessing LV: Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipolar Disord 2008; 10:87–94
 
3.Marangell LB, Dennehy EB, Wisniewski SR, Bauer MS, Miyahara S, Allen MH, Martinez M, Al Jurdi RK, Thase ME: Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD. J Clin Psychiatry 2008; 8:e1–e7
 
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 35.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 54.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 62.  >
Textbook of Traumatic Brain Injury, 2nd Edition > Chapter 35.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles
Aripiprazole alone or in combination for acute mania. Cochrane Database Syst Rev 2013;12():CD005000.